CORRECTION article

Front. Pharmacol., 07 November 2022

Sec. Ethnopharmacology

Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1073679

Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis

  • 1. Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy

  • 2. Department of Chemical, Biological, Pharmaceutical and Environmental Sciences, University of Messina, Messina, Italy

  • 3. Department of Biomedical and Dental Sciences and Morphofunctional Imaging, University of Messina, Messina, Italy

In the published article, the Conflict of Interest statement was incorrectly filed. The correct Conflict of Interest statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Statements

Conflict of interest

Author DA is co-inventor on a patent related to curcumin synergy in anti-inflammatory formulations. Author FS has received research support from Primus Pharmaceuticals for work on genistein.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

synergy, curcumin, flavocoxid, beta-caryophyllene, inflammation

Citation

D’Ascola A, Irrera N, Ettari R, Bitto A, Pallio G, Mannino F, Atteritano M, Campo GM, Minutoli L, Arcoraci V, Squadrito V, Picciolo G, Squadrito F and Altavilla D (2022) Corrigendum: Exploiting curcumin synergy with natural products using quantitative analysis of dose-effect relationships in an experimental in vitro model of osteoarthritis. Front. Pharmacol. 13:1073679. doi: 10.3389/fphar.2022.1073679

Received

18 October 2022

Accepted

19 October 2022

Published

07 November 2022

Approved by

Frontiers Editorial Office Frontiers Media SA, Switzerland

Volume

13 - 2022

Updates

Copyright

*Correspondence: Francesco Squadrito,

†These authors have contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics